The absence of any active CDC Level 4 "Avoid All Travel" notices, combined with recent Level 2 "Practice Enhanced Precautions" alerts for meningococcal disease in the Democratic Republic of the Congo (issued March 24, 2026) and yellow fever increases in Venezuela (March 16), underpins trader consensus implying a 74% probability of "No" new Level 4 by December 31. These designations reflect contained outbreaks where precautions like vaccinations suffice, far below Level 4 criteria of extreme, unpreventable health risks such as widespread Ebola transmission. Global polio remains at Level 2 (updated March 9), while surging measles cases prompt only Level 1 guidance. With no escalations in CDC surveillance data over the past month, markets anticipate epidemiological stability barring unforeseen pathogen emergences; watch weekly outbreak reports for shifts.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गयाCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$69,767 वॉल्यूम
$69,767 वॉल्यूम
31 दिस, 2026
$69,767 वॉल्यूम
$69,767 वॉल्यूम
31 दिस, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.The absence of any active CDC Level 4 "Avoid All Travel" notices, combined with recent Level 2 "Practice Enhanced Precautions" alerts for meningococcal disease in the Democratic Republic of the Congo (issued March 24, 2026) and yellow fever increases in Venezuela (March 16), underpins trader consensus implying a 74% probability of "No" new Level 4 by December 31. These designations reflect contained outbreaks where precautions like vaccinations suffice, far below Level 4 criteria of extreme, unpreventable health risks such as widespread Ebola transmission. Global polio remains at Level 2 (updated March 9), while surging measles cases prompt only Level 1 guidance. With no escalations in CDC surveillance data over the past month, markets anticipate epidemiological stability barring unforeseen pathogen emergences; watch weekly outbreak reports for shifts.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
बाज़ार खुला: Jan 19, 2026, 3:15 PM ET
वॉल्यूम
$69,767समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.The absence of any active CDC Level 4 "Avoid All Travel" notices, combined with recent Level 2 "Practice Enhanced Precautions" alerts for meningococcal disease in the Democratic Republic of the Congo (issued March 24, 2026) and yellow fever increases in Venezuela (March 16), underpins trader consensus implying a 74% probability of "No" new Level 4 by December 31. These designations reflect contained outbreaks where precautions like vaccinations suffice, far below Level 4 criteria of extreme, unpreventable health risks such as widespread Ebola transmission. Global polio remains at Level 2 (updated March 9), while surging measles cases prompt only Level 1 guidance. With no escalations in CDC surveillance data over the past month, markets anticipate epidemiological stability barring unforeseen pathogen emergences; watch weekly outbreak reports for shifts.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
वॉल्यूम
$69,767समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...The absence of any active CDC Level 4 "Avoid All Travel" notices, combined with recent Level 2 "Practice Enhanced Precautions" alerts for meningococcal disease in the Democratic Republic of the Congo (issued March 24, 2026) and yellow fever increases in Venezuela (March 16), underpins trader consensus implying a 74% probability of "No" new Level 4 by December 31. These designations reflect contained outbreaks where precautions like vaccinations suffice, far below Level 4 criteria of extreme, unpreventable health risks such as widespread Ebola transmission. Global polio remains at Level 2 (updated March 9), while surging measles cases prompt only Level 1 guidance. With no escalations in CDC surveillance data over the past month, markets anticipate epidemiological stability barring unforeseen pathogen emergences; watch weekly outbreak reports for shifts.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया
बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न